Fukui Y

No ORCID on file · 15 papers in corpus · active 2019-2026

Study types

  • article 6
  • other 2
  • case-report 1

Condition tags

  • adenomyosis 8
  • dysmenorrhea 5
  • endometriosis 3
  • infertility 3
  • endometrioma 1
  • disambig:endometritis 1
article 2026
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2026.105699

RESEARCH QUESTION: Does adenomyosis increase the risk of thromboembolic events, including both arterial and venous thromboembolism, compared with endometriosis, and what clinical factors may contribute to this association? DESIGN: This ret…

other 2026
Journal of the Endocrine Society ·doi:10.1210/jendso/bvag056

Adenomyosis is an intractable gynecological disorder that can give rise to severe pelvic pain, heavy menstrual bleeding, and infertility, predominantly affecting women of reproductive age. The limited efficacy of current pharmacological int…

2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70028

PurposeRecurrent implantation failure (RIF) is a form of refractory infertility that persists despite assisted reproductive technology. Cine magnetic resonance imaging (cine MRI) enables the visualization of uterine peristalsis; however, it…

2025
Scientific reports ·doi:10.1038/s41598-025-92906-9

Chronic endometritis (CE) and endometrial dysbiosis (ED) are major causes of recurrent implantation failure (RIF). CE is diagnosed via hysteroscopy or the endometrial CD138 test; ED is examined using endometrial microbiome testing with next…

2025
Scientific reports ·doi:10.1038/s41598-025-27867-0

Assisted hatching (AH) is a reproductive technique that artificially thins or breaches the zona pellucida to facilitate hatching. Despite its widespread use, there is insufficient evidence to conclude that AH improves pregnancy outcomes, pa…

article 2025
BMC women's health ·doi:10.1186/s12905-025-03817-w

Adenomyosis often causes dysmenorrhea in women of reproductive age. Progestins such as levonorgestrel intrauterine system (LNG-IUS) are often used for treatment, but some patients experience progesterone resistance, showing poor treatment r…

case-report 2024
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.16185

Uterine adenomyosis is a common disease in women of reproductive age that causes dysmenorrhea, abnormal uterine bleeding, infertility, and obstetric complications. Rarely, adenomyosis can lead to abscess formation, which is refractory to an…

2024
Trials ·doi:10.1186/s13063-024-07923-2

BackgroundUterine leiomyomas are common for reproductive-aged women and affect women's quality of life due to heavy menstrual bleeding or dysmenorrhea. Leiomyomas grow according to estradiol exposure and decrease after post-menopause. In ca…

other 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-022-01077-9

Levonorgestrel-releasing intrauterine system (LNG-IUS) relieves dysmenorrhea and heavy menstrual bleeding (HMB) in adenomyosis. However, its efficacy on health-related quality of life (HR-QOL) in patients with symptomatic adenomyosis remain…

article 2023
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05956-0

BACKGROUND: Adenomyosis is a common gynecological disease in women of reproductive age and causes various symptoms such as dysmenorrhea and heavy menstrual bleeding. However, the influence of pregnancy on the progression of adenomyosis rema…

2023
Cell death & disease ·doi:10.1038/s41419-023-05832-x

Infertility occurs in 15% of couples worldwide. Recurrent implantation failure (RIF) is one of the major problems in in vitro fertilization and embryo transfer (IVF-ET) programs, and how to manage patients with RIF to achieve successful pre…

article 2022
Endocrinology ·doi:10.1210/endocr/bqac044

Adenomyosis is a benign uterine disease that causes dysmenorrhea, heavy menstrual bleeding, and infertility; however, its pathophysiology remains unclear. Since signal transducer and activator of transcription 3 (STAT3) is crucial for endom…

article 2022
Diagnostics ·doi:10.3390/diagnostics12051212

This study aimed to evaluate the prediction efficacy of malignant transformation of ovarian endometrioma (OE) using the Copenhagen Index (CPH-I), the risk of ovarian malignancy algorithm (ROMA), and the R2 predictive index. This retrospecti…

2020
Cell death & disease ·doi:10.1038/s41419-020-2559-0
article 2019
Nature communications ·doi:10.1038/s41467-019-13708-y

Uterine adenomyosis is a benign disorder that often co-occurs with endometriosis and/or leiomyoma, and impairs quality of life. The genomic features of adenomyosis are unknown. Here we apply next-generation sequencing to adenomyosis (70 ind…